Cirugia Cardiovascular最新文献

{"title":"Un gigante, un maestro de la cirugía cardíaca pediátrica, una buena persona, pero sobre todo un gran amigo","authors":"Alberto Juffé Stein","doi":"10.1016/j.circv.2025.05.003","DOIUrl":"10.1016/j.circv.2025.05.003","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Page 229"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factor de impacto, indexación en PubMed y nuevos monográficos en Cirugía Cardiovascular","authors":"Rafael García Fuster","doi":"10.1016/j.circv.2025.05.002","DOIUrl":"10.1016/j.circv.2025.05.002","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Page 189"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"TAVI transcarotídeo: la técnica paso a paso","authors":"Federico Altamirano-Medel,&nbsp;Miguel A. Gomez-Vidal,&nbsp;Tomás Daroca-Martinez","doi":"10.1016/j.circv.2024.05.006","DOIUrl":"10.1016/j.circv.2024.05.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Transcatheter aortic valve implantation as a treatment for aortic stenosis is positioned as the therapy of choice for a specific population of patients, which is steadily increasing and is no longer limited to patients with prohibitively high surgical risk. This stems from the advancement and refinement of devices, as well as the development of different access routes. Our goal is to share and standardize the transcarotid access technique, which we have implemented and developed since 2019 with very good results.</div></div><div><h3>Method and results</h3><div>Between 01/01/2019 and 31/12/2023, 79 transcatheter valves were implanted via the carotid route (21.43% of the total implants in our center), with no intraoperative mortality and less than 1% mortality during the first month of intervention. The incidence of established strokes in these patients is 0%.</div></div><div><h3>Conclusions</h3><div>We have adopted the transcarotid route as an equally valid alternative to the transaxillary access. Due to recent changes in patient selection criteria, we believe that the cardiovascular surgeon should have an active role in decision-making and implantation of this type of prosthesis, since many patients have low surgical risk and are consequently susceptible to intervention in case of procedure complications.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 201-207"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resultados comparativos de las vías transvasculares no femorales en un mismo centro, 11 años de nuestro programa TAVI","authors":"Federico Altamirano-Medel,&nbsp;Jose Manuel Vignau Cano,&nbsp;Diego Macias-Rubio,&nbsp;Juan Otero-Forero,&nbsp;Miguel A. Gomez-Vidal,&nbsp;Anibal Bermudez Garcia,&nbsp;Cristina Jaen-Garrido,&nbsp;Eloy Rueda-Gomariz,&nbsp;Adrian Fontaine,&nbsp;Jose Mamani-Moriano,&nbsp;Patric Callero-Hernandez,&nbsp;Tomás Daroca-Martinez","doi":"10.1016/j.circv.2024.10.003","DOIUrl":"10.1016/j.circv.2024.10.003","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Alternative “non-femoral” access routes are presented as an alternative option in current clinical guidelines for transcatheter valve implantation when the femoral route is not possible. Our main objective is describing the activity carried out in our center and to show the results of a series of transcatheter aortic prostheses implanted exclusively by a team of cardiovascular surgeons.</div></div><div><h3>Methods</h3><div>Descriptive study of a series of TAVIs implanted by cardiovascular surgeons with non-transfemoral approach. Data collection on preoperative variables and postoperative variables.</div></div><div><h3>Results</h3><div>304 non-transfemoral TAVI: 21 implants with transaortic access (6.91%), 62 transapical access (20.40%), 168 transaxillary (55.26%) and 53 transcarotid (17.43%). A total of 69.73% (212) implantations were with self-expandable prostheses and 30.27% (92) with balloon expandable prostheses. A total of 65 leaks (21.38%) were registered. First year mortality was 5.38%. Three ischaemic strokes (0.98%).</div><div>Forty-five patients (14.80%) required implantation of a permanent pacemaker. There were 4 vascular complications in the case of the transaxillary approach (2.43%) and 1 in the case of the transapical approach (1.62%).</div></div><div><h3>Conclusions</h3><div>Balloon expandable prostheses have lower blockage rates and fewer periprosthetic leaks but slightly higher mortality (non-significant). The transaxillary and transcarotid access are not inferior to the transfemoral access in terms of morbidity and mortality. Vascular non-transfemoral access should be considered an option when they are of better quality. The transcarotid access is positioning itself as a possibly better alternative to the transaxillary access.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 216-222"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implante de TAVI transapical combinado con cirugía coronaria mínimamente invasiva","authors":"Carmen Iglesias ,&nbsp;Francisco Estévez ,&nbsp;Adrián Muinelo ,&nbsp;José Joaquín Cuenca","doi":"10.1016/j.circv.2024.05.001","DOIUrl":"10.1016/j.circv.2024.05.001","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 223-225"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tratamiento de disfunción protésica aórtica transcatéter mediante explante e implante de nueva prótesis aórtica transcatéter in situ","authors":"Pilar Garrido-Martín ,&nbsp;José R. González-Rodríguez ,&nbsp;Nora García-Borges ,&nbsp;Javier Montoto-López ,&nbsp;Rafael Martínez-Sanz","doi":"10.1016/j.circv.2024.09.003","DOIUrl":"10.1016/j.circv.2024.09.003","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 226-228"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Credits","authors":"","doi":"10.1016/S1134-0096(25)00169-X","DOIUrl":"10.1016/S1134-0096(25)00169-X","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Page i"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Abordajes intratorácicos versus extratorácicos en la implantación de válvula aórtica transcatéter no transfemoral: un análisis de puntuación de propensidad","authors":"Víctor X. Mosquera ,&nbsp;Adrian Muinelo-Paul ,&nbsp;Laura Fernandez-Arias ,&nbsp;Miguel Gonzalez-Barbeito ,&nbsp;José Manuel Martínez-Comendador ,&nbsp;Carmen Iglesias-Gil ,&nbsp;Guillermo Ventosa Fernández ,&nbsp;María García Vieites ,&nbsp;Carlos Velasco García ,&nbsp;José J. Cuenca-Castillo","doi":"10.1016/j.circv.2024.06.005","DOIUrl":"10.1016/j.circv.2024.06.005","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to compare the outcomes of extrathoracic (ET) transcatheter aortic valve implantation (TAVI) to intrathoracic (IT) TAVI, specifically focusing on in-hospital or 30-day all-cause mortality (ACM), postoperative and 30-day complications, and 1-year ACM.</div></div><div><h3>Methods</h3><div>Between January 2009 and December 2023, 447 non-TF TAVI procedures were performed at our institution. Patients were categorized into IT (transapical) and ET (transcarotid and transaxillary) accesses. Propensity score matching was employed to compare outcomes between the two groups.</div></div><div><h3>Results</h3><div>Patients undergoing ET TAVI were older (mean age: 81.9 vs. 79.5 years) and had a higher prevalence of peripheral vascular and coronary artery diseases. ET TAVI was associated with a lower 30-day mortality rate (1.6% vs. 10.2%, <em>P</em> <!-->=<!--> <!-->.006) and fewer respiratory complications (0.8% vs. 19.9%, <em>P</em> <!-->&lt;<!--> <!-->.001) compared to IT TAVI. The 1-year ACM was significantly lower in the ET group compared to the IT group. No significant differences were observed in procedural success rates, device success rates, or hemodynamic outcomes between the two groups. The ET group demonstrated consistently higher survival probabilities throughout the study period (<em>P</em> <!-->&lt;<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>ET TAVI appears to offer advantages in terms of lower short-term and 1-year mortality, as well as reduced postoperative complications compared to IT TAVI. Both approaches are comparable in terms of procedural and hemodynamic outcomes. These findings can assist clinicians in selecting the most appropriate TAVI approach tailored to individual patient profiles.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 208-215"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144596609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resultados de procedimientos híbridos de cirugía coronaria e implante transcatéter de la válvula aórtica concomitante","authors":"Carlos Domínguez-Massa ,&nbsp;Tomás Heredia-Cambra ,&nbsp;Juan Bautista Martínez-León","doi":"10.1016/j.circv.2024.02.012","DOIUrl":"10.1016/j.circv.2024.02.012","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Coronary artery disease may be present in 40-75% of patients with severe aortic stenosis who undergo transcatheter aortic valve implantation (TAVI). The aim is to evaluate the safety of a hybrid procedure in which coronary artery bypass grafting and TAVI are performed simultaneously with respect to conventional coronary artery bypass grafting and aortic prosthesis implantation with cardiopulmonary bypass.</div></div><div><h3>Methods</h3><div>Patients who underwent TAVI concomitantly with coronary revascularization off-pump were analyzed, consecutively, from when this procedure began in 2017 until the last patient operated on in 2020 (n<!--> <!-->=<!--> <!-->19), compared with the cases operated on for biological aortic prosthesis implantation, with cardiopulmonary bypass, concomitantly with surgical coronary revascularization, in the last year 2021 (n<!--> <!-->=<!--> <!-->24). Unified Valve Academic Research Consortium 3 (VARC-3) parameters were used.</div></div><div><h3>Results</h3><div>Regarding the preoperative variables, statistically significant differences were found in mean age (77,89<!--> <!-->±<!--> <!-->5,91 years in the TAVI group compared to 70,33<!--> <!-->±<!--> <!-->5,48 years in the conventional surgery group; p<!--> <!-->&lt;<!--> <!-->0.001), and in the rate of vascular disease (63,2% vs. 25%; p<!--> <!-->=<!--> <!-->0,012). No differences were found in the number of coronary anastomoses performed between the two groups. In the postoperative results, only statistically significant differences were found in the rate of paravalvular regurgitation (47,4% vs. 8,3%; p<!--> <!-->=<!--> <!-->0.005).</div></div><div><h3>Conclusion</h3><div>TAVI concomitantly with coronary artery bypass grafting has been shown to be safe with no statistically significant differences in the primary endpoints of mortality, stroke rate, and reoperations, as well as in the combined endpoints of technical success, device success, early safety, and of clinical efficacy.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 195-200"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140777863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Descripción técnica y resultados del implante transcatéter valvular aórtico transcarotídeo. Experiencia de nuestro centro","authors":"Omar A. Araji-Tiliani ,&nbsp;José M. Barquero-Aroca ,&nbsp;Rafael Hidalgo-Urbano ,&nbsp;Román Calvo-Jambrina","doi":"10.1016/j.circv.2024.01.007","DOIUrl":"10.1016/j.circv.2024.01.007","url":null,"abstract":"<div><h3>Introduction</h3><div>Transcatheter aortic valve implantation is the first-line technique in patients older than 75<!--> <!-->years. The transfemoral access is the more frequently used, but 15% to 20% of patients have severe peripheral vascular disease, which precludes its use. As an alternative, the axillary route is used and recently the carotid route.</div><div>In this paper we present our experience, describe our technique, and report our results with a follow up of 40 months maximum and mean (8,32<!--> <!-->±<!--> <!-->10,12 months).</div></div><div><h3>Material and methods</h3><div>25 patients were operated on during this interval (January 2020-June 2023), 84% men, age 78.88<!--> <!-->±<!--> <!-->6.3, 100% hypertensive and with significant peripheral arterial disease, STS score 4.46<!--> <!-->±<!--> <!-->0.87, 80% dyslipidemic, 60% NYHA<!--> <!-->III-IV, 44% chronic renal failure, 80% chronic ischemic heart disease, 28% previous stroke, COPD 48%, 16% patent left internal mammary bypass, and 24% of previous cardiac surgery. The prostheses used were Sapien<!--> <!-->3 (36%), Portico-Navitor (60%) and Accurate Neo (4%).</div></div><div><h3>Results</h3><div>Mortality at 30 days 4%, at one year 9%, AVC 4%, AMI 4%. Implant success 100%, pacemaker implantation 12%. We did not obtain CRF exacerbation, major or minor bleeding, perforation of LV or pericardial effusion, malpositioning or implantation of more than one prosthesis, or coronary obstruction. More than mild periprosthetic insufficiency was 4%.</div></div><div><h3>Conclusions</h3><div>The transcarotid transcatheter implantation is feasible, with good results, to take into account its use when the femoral and axillary accesses are not suitable.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 4","pages":"Pages 190-194"},"PeriodicalIF":0.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140464812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}